Literature DB >> 19074637

Adiponectin deficiency does not affect development and progression of spontaneous colitis in IL-10 knockout mice.

Maria Pini1, Melissa E Gove, Raja Fayad, Robert J Cabay, Giamila Fantuzzi.   

Abstract

The goal of this study was to investigate the role of the adipokine adiponectin (APN) in development of spontaneous colitis in IL-10 knockout (KO) mice. To this aim, we generated double IL-10 APN KO mice and compared their disease development to that of single IL-10 KO mice. Both IL-10 KO and double IL-10 APN KO mice spontaneously developed colitis of comparable severity. No significant differences in inflammatory infiltrate or crypt elongation were observed in colonic tissue obtained from IL-10 KO and double IL-10 APN KO mice at either 12 or 20 wk of age. A comparable increase in circulating levels of serum amyloid A and IFN-gamma was observed in IL-10 KO and double IL-10 APN KO mice as disease progressed. In vitro stimulation of lymphocytes from mesenteric lymph nodes with anti-CD3 and anti-CD28 induced a significantly higher production of IL-17 and TNF-alpha in IL-10 KO and double IL-10 APN KO mice compared with their healthy littermates. No significant differences in cytokine production from lymphocytes or colonic mRNA expression of cytokines were observed between IL-10 KO and double IL-10 APN KO mice. Both IL-10 KO and double IL-10 APN KO mice had a similar decrease in body weight and bone mass compared with their respective healthy littermates. Finally, APN deficiency did not lead to development of insulin resistance, either in APN KO or double IL-10 APN KO mice. In conclusion, lack of APN does not play a significant role in the pathogenesis of spontaneous colonic inflammation in the IL-10 KO model.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19074637      PMCID: PMC2643903          DOI: 10.1152/ajpgi.90593.2008

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  32 in total

Review 1.  Immunopathogenesis of inflammatory bowel disease.

Authors:  David Q Shih; Stephan R Targan
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

Review 2.  Adiponectin receptors, with special focus on the role of the third receptor, T-cadherin, in vascular disease.

Authors:  Tamotsu Takeuchi; Yoshihiro Adachi; Yuji Ohtsuki; Mutsuo Furihata
Journal:  Med Mol Morphol       Date:  2007-09-18       Impact factor: 2.309

Review 3.  Mouse models of inflammatory bowel disease.

Authors:  Stefan Wirtz; Markus F Neurath
Journal:  Adv Drug Deliv Rev       Date:  2007-08-16       Impact factor: 15.470

4.  Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk.

Authors:  Virginia G Kaklamani; Kari B Wisinski; Maureen Sadim; Cassandra Gulden; Albert Do; Kenneth Offit; John A Baron; Habibul Ahsan; Christos Mantzoros; Boris Pasche
Journal:  JAMA       Date:  2008-10-01       Impact factor: 56.272

Review 5.  Adipokines as emerging mediators of immune response and inflammation.

Authors:  Francisca Lago; Carlos Dieguez; Juan Gómez-Reino; Oreste Gualillo
Journal:  Nat Clin Pract Rheumatol       Date:  2007-12

Review 6.  Adiponectin and inflammation: consensus and controversy.

Authors:  Giamila Fantuzzi
Journal:  J Allergy Clin Immunol       Date:  2007-12-03       Impact factor: 10.793

7.  Adiponectin induces interleukin-6 production and activates STAT3 in adult mouse cardiac fibroblasts.

Authors:  Wenqiang Liao; Changan Yu; Jianyan Wen; William Jia; Geng Li; Yuannan Ke; Shumin Zhao; William Campell
Journal:  Biol Cell       Date:  2009-05       Impact factor: 4.458

8.  Adiponectin enhances IL-6 production in human synovial fibroblast via an AdipoR1 receptor, AMPK, p38, and NF-kappa B pathway.

Authors:  Chih-Hsin Tang; Yung-Cheng Chiu; Tzu-Wei Tan; Rong-Sen Yang; Wen-Mei Fu
Journal:  J Immunol       Date:  2007-10-15       Impact factor: 5.422

9.  Adiponectin is a negative regulator of bone mineral and bone strength in growing mice.

Authors:  Kafi N Ealey; Jovana Kaludjerovic; Michael C Archer; Wendy E Ward
Journal:  Exp Biol Med (Maywood)       Date:  2008-10-10

10.  Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake.

Authors:  Naoto Kubota; Wataru Yano; Tetsuya Kubota; Toshimasa Yamauchi; Shinsuke Itoh; Hiroki Kumagai; Hideki Kozono; Iseki Takamoto; Shiki Okamoto; Tetsuya Shiuchi; Ryo Suzuki; Hidemi Satoh; Atsushi Tsuchida; Masao Moroi; Kaoru Sugi; Tetsuo Noda; Hiroyuki Ebinuma; Yoichi Ueta; Tatsuya Kondo; Eiichi Araki; Osamu Ezaki; Ryozo Nagai; Kazuyuki Tobe; Yasuo Terauchi; Kohjiro Ueki; Yasuhiko Minokoshi; Takashi Kadowaki
Journal:  Cell Metab       Date:  2007-07       Impact factor: 27.287

View more
  13 in total

Review 1.  Extraluminal factors contributing to inflammatory bowel disease.

Authors:  Arvind Batra; Thorsten Stroh; Britta Siegmund
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

2.  Differential effects of energy balance on experimentally-induced colitis.

Authors:  Sarah J McCaskey; Elizabeth A Rondini; Ingeborg M Langohr; Jenifer I Fenton
Journal:  World J Gastroenterol       Date:  2012-02-21       Impact factor: 5.742

3.  Adiponectin receptor signaling on dendritic cells blunts antitumor immunity.

Authors:  Peng H Tan; Helen E J Tyrrell; Liquan Gao; Danmei Xu; Jianchao Quan; Dipender Gill; Lena Rai; Yunchuan Ding; Gareth Plant; Yuan Chen; John Z Xue; Ashok I Handa; Michael J Greenall; Kenneth Walsh; Shao-An Xue
Journal:  Cancer Res       Date:  2014-09-26       Impact factor: 12.701

4.  A role of the aryl hydrocarbon receptor in attenuation of colitis.

Authors:  Keisuke Furumatsu; Shin Nishiumi; Yuki Kawano; Makoto Ooi; Tomoo Yoshie; Yuuki Shiomi; Hiromu Kutsumi; Hitoshi Ashida; Yoshiaki Fujii-Kuriyama; Takeshi Azuma; Masaru Yoshida
Journal:  Dig Dis Sci       Date:  2011-03-05       Impact factor: 3.199

Review 5.  Adiponectin in inflammatory and immune-mediated diseases.

Authors:  Giamila Fantuzzi
Journal:  Cytokine       Date:  2013-07-11       Impact factor: 3.861

6.  Effects of obesity on severity of colitis and cytokine expression in mouse mesenteric fat. Potential role of adiponectin receptor 1.

Authors:  Aristea Sideri; Dimitris Stavrakis; Collin Bowe; David Q Shih; Phillip Fleshner; Violeta Arsenescu; Razvan Arsenescu; Jerrold R Turner; Charalabos Pothoulakis; Iordanes Karagiannides
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-01-15       Impact factor: 4.052

7.  Adiponectin and plant-derived mammalian adiponectin homolog exert a protective effect in murine colitis.

Authors:  Violeta Arsenescu; Meena L Narasimhan; Tuna Halide; Ray A Bressan; Chiara Barisione; Donald A Cohen; Willem J S de Villiers; Razvan Arsenescu
Journal:  Dig Dis Sci       Date:  2011-04-11       Impact factor: 3.199

8.  Inflammation-induced functional connectivity of melanin-concentrating hormone and IL-10.

Authors:  Dimitrios C Ziogas; Apostolos K A Karagiannis; Brenda M Geiger; Beatriz Gras-Miralles; Robert Najarian; Ofer Reizes; Leo R Fitzpatrick; Efi Kokkotou
Journal:  Peptides       Date:  2014-02-18       Impact factor: 3.750

9.  Adiponectin deficiency modulates adhesion molecules expression and cytokine production but does not affect disease severity in the transfer model of colitis.

Authors:  Melissa E Gove; Maria Pini; Raja Fayad; Robert J Cabay; Giamila Fantuzzi
Journal:  Cytokine       Date:  2009-06-10       Impact factor: 3.861

Review 10.  Adipokines and the role of visceral adipose tissue in inflammatory bowel disease.

Authors:  Thomas Karrasch; Andreas Schaeffler
Journal:  Ann Gastroenterol       Date:  2016-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.